← Open Payments lookup

AMANDA HAM: Open Payments

NPI 1912220237 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$36,556 in 155 payments from 9 companies in 2025. Trend: 2023 $11,143 · 2024 $5,707 · 2025 $36,556

Speaker / faculty: $28,040Consulting: $3,188Food & beverage: $2,884Travel & lodging: $2,386Education: $58
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)62$27,726
ABBVIE INC.29$7,505
E.R. Squibb & Sons, L.L.C.11$342
Axsome Therapeutics, Inc.12$282
Teva Pharmaceuticals USA, Inc.13$249
Neurocrine BioSciences, Inc.14$229
Alkermes, Inc.11$169
Otsuka America Pharmaceutical, Inc.2$34
Vanda Pharmaceuticals Inc.1$21

Products named: CAPLYTA, VRAYLAR, COBENFY, Auvelity, INGREZZA, AUSTEDO XR, ARISTADA, REXULTI.

Industry payments across MS — which companies pay providers there.